Dodge & Cox Sells 1,573 Shares of Eli Lilly and Company

Hedge fund reduces stake in pharmaceutical giant

Mar. 14, 2026 at 8:09am

Got story updates? Submit your updates here. ›

Dodge & Cox, a prominent investment management firm, reduced its stake in Eli Lilly and Company by 3.5% in the third quarter, selling 1,573 shares of the pharmaceutical company's stock. The fund now owns 43,384 shares of Eli Lilly, valued at $33,102,000 as of the most recent SEC filing.

Why it matters

Eli Lilly is one of the world's leading pharmaceutical companies, known for its innovative drugs and therapies. The reduction in Dodge & Cox's stake, while relatively small, could signal a shift in the firm's investment strategy or outlook on the company's future performance.

The details

According to the SEC filing, Dodge & Cox sold 1,573 shares of Eli Lilly and Company during the third quarter, reducing its total stake in the company to 43,384 shares. The firm's holdings in Eli Lilly were valued at $33,102,000 as of the filing. The sale comes as Eli Lilly's stock has seen significant gains, with the share price rising from around $623 to over $1,000 in the past year.

  • Dodge & Cox reduced its stake in Eli Lilly and Company during the third quarter of 2026.

The players

Dodge & Cox

A prominent investment management firm that has reduced its stake in Eli Lilly and Company.

Eli Lilly and Company

A global pharmaceutical company known for its innovative drugs and therapies.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Dodge & Cox's stake in Eli Lilly and Company, while relatively small, could signal a shift in the firm's investment strategy or outlook on the pharmaceutical company's future performance. Investors will be closely watching Eli Lilly's stock and any further changes in institutional ownership.